| scholarly article | Q13442814 |
| P50 | author | Robert S. Negrin | Q110528996 |
| P2093 | author name string | Ronald Levy | |
| Robert Zeiser | |||
| Jing-Zhou Hou | |||
| Weiyun Z Ai | |||
| Debra Czerwinski | |||
| P2860 | cites work | Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25– T cells | Q24645614 |
| CD70+ non-Hodgkin lymphoma B cells induce Foxp3 expression and regulatory function in intratumoral CD4+CD25 T cells | Q24681974 | ||
| Chemoattractants MDC and TARC are secreted by malignant B-cell precursors following CD40 ligation and support the migration of leukemia-specific T cells | Q28208074 | ||
| Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4+, CD40L+ T cells by producing CCL22 | Q28216101 | ||
| Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival | Q29547865 | ||
| Immunosuppressive networks in the tumour environment and their therapeutic relevance | Q29619244 | ||
| Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma. | Q33217202 | ||
| Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells | Q34103579 | ||
| Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells | Q34147162 | ||
| Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity | Q34505678 | ||
| Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. | Q34515741 | ||
| Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development | Q34597933 | ||
| Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival | Q35839898 | ||
| Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma | Q35849633 | ||
| Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells | Q36384673 | ||
| Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors | Q36402716 | ||
| Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells. | Q36403529 | ||
| Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation | Q36403539 | ||
| CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner | Q36403637 | ||
| Attenuation of CD8(+) T-cell function by CD4(+)CD25(+) regulatory T cells in B-cell non-Hodgkin's lymphoma | Q37188161 | ||
| Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells | Q38336314 | ||
| Specific recruitment of CC chemokine receptor 4-positive regulatory T cells in Hodgkin lymphoma fosters immune privilege | Q40272799 | ||
| Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells | Q40498116 | ||
| Selective induction of Th2-attracting chemokines CCL17 and CCL22 in human B cells by latent membrane protein 1 of Epstein-Barr virus | Q40595020 | ||
| Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand | Q42767299 | ||
| Depletion of CD25(+) CD4(+) T cells and treatment with tyrosinase-related protein 2-transduced dendritic cells enhance the interferon alpha-induced, CD8(+) T-cell-dependent immune defense of B16 melanoma. | Q43829312 | ||
| Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL). | Q46525283 | ||
| Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer | Q46549031 | ||
| Local and systemic induction of CD4+CD25+ regulatory T-cell population by non-Hodgkin lymphoma | Q46729711 | ||
| Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment. | Q50993468 | ||
| Regulation of trafficking receptor expression in human forkhead box P3+ regulatory T cells. | Q51981296 | ||
| In vivo peripheral expansion of naive CD4+CD25high FoxP3+ regulatory T cells in patients with multiple myeloma. | Q51985543 | ||
| Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma. | Q53338355 | ||
| Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma | Q56904280 | ||
| Heavy chain ferritin activates regulatory T cells by induction of changes in dendritic cells | Q56904454 | ||
| Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells | Q57279527 | ||
| Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells | Q58234949 | ||
| Depletion of CD25+ regulatory cells uncovers immune responses to shared murine tumor rejection antigens | Q61791929 | ||
| Association of increased levels of heavy-chain ferritin with increased CD4+ CD25+ regulatory T-cell levels in patients with melanoma | Q73653007 | ||
| Follicular lymphoma intratumoral CD4+CD25+GITR+ regulatory T cells potently suppress CD3/CD28-costimulated autologous and allogeneic CD8+CD25- and CD4+CD25- T cells | Q79984745 | ||
| Fatal attraction: tumors beckon regulatory T cells | Q80513353 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | follicular lymphoma | Q123251 |
| P304 | page(s) | 239-244 | |
| P577 | publication date | 2009-01-01 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | Follicular lymphoma B cells induce the conversion of conventional CD4+ T cells to T-regulatory cells | |
| P478 | volume | 124 |
| Q35902658 | Association of HLA-DQB1 alleles with risk of follicular lymphoma |
| Q46866928 | B-cell receptor signaling and CD40 ligand-independent T cell help cooperate in Helicobacter-induced MALT lymphomagenesis. |
| Q43199543 | Clinicobiological, prognostic and therapeutic implications of the tumor microenvironment in follicular lymphoma |
| Q36922528 | Cross talk between follicular Th cells and tumor cells in human follicular lymphoma promotes immune evasion in the tumor microenvironment |
| Q38873898 | Follicular Lymphoma: The Role of the Tumor Microenvironment in Prognosis |
| Q37427993 | Follicular lymphoma cells induce T-cell immunologic synapse dysfunction that can be repaired with lenalidomide: implications for the tumor microenvironment and immunotherapy |
| Q37783953 | Follicular lymphoma prognostic factors in the modern era: what is clinically meaningful? |
| Q64087351 | Germinal center-derived lymphomas: The darkest side of humoral immunity |
| Q36628291 | High PD-1 expression and suppressed cytokine signaling distinguish T cells infiltrating follicular lymphoma tumors from peripheral T cells. |
| Q36246716 | High ratio of interfollicular CD8/FOXP3-positive regulatory T cells is associated with a high FLIPI index and poor overall survival in follicular lymphoma |
| Q39525598 | Immune adaptive microenvironment profiles in intracerebral and intrasplenic lymphomas share common characteristics |
| Q22252252 | Immunosenescence and cancer |
| Q55295666 | Immunosuppressive Treg cells acquire the phenotype of effector-T cells in chronic lymphocytic leukemia patients. |
| Q37777299 | Implications of the tumor microenvironment on survival and disease response in follicular lymphoma |
| Q34194680 | In situ vaccination with a TLR9 agonist induces systemic lymphoma regression: a phase I/II study |
| Q36555546 | Increased frequency of suppressive regulatory T cells and T cell-mediated antigen loss results in murine melanoma recurrence |
| Q52562303 | Inhibiting IL-2 signaling and the regulatory T-cell pathway using computationally designed peptides. |
| Q37685586 | Low NK cell counts in peripheral blood are associated with inferior overall survival in patients with follicular lymphoma. |
| Q26782902 | Lymphoma Immunotherapy: Current Status |
| Q28080705 | Lymphoma: immune evasion strategies |
| Q34103249 | Malignant B cells induce the conversion of CD4+CD25- T cells to regulatory T cells in B-cell non-Hodgkin lymphoma |
| Q37269044 | New developments in the pathology of malignant lymphoma: a review of the literature published from August to December 2008. |
| Q38636284 | Nivolumab for the treatment of classical Hodgkin lymphoma after failure of autologous stem cell transplant and brentuximab |
| Q36290288 | Pathogenesis of follicular lymphoma |
| Q37810119 | Prognostic tools in follicular lymphomas |
| Q84073243 | Regulatory T cells in cancer |
| Q35154940 | Selective targeting of Toll-like receptors and OX40 inhibit regulatory T-cell function in follicular lymphoma |
| Q37971736 | Structure and function of the hematopoietic cancer niche: focus on chronic lymphocytic leukemia |
| Q37960166 | T regulatory cells in B-cell malignancy - tumour support or kiss of death? |
| Q38344066 | T-cell-mediated antitumor immunity in B-cell non-Hodgkin lymphoma: activation, suppression and exhaustion |
| Q37966000 | The four types of Tregs in malignant lymphomas |
| Q27687567 | The tumor microenvironment shapes hallmarks of mature B-cell malignancies |
| Q38227748 | The tumour microenvironment in B cell lymphomas |
| Q93379103 | Tumor-infiltrating regulatory T cells: origins and features |
| Q39043404 | Vaccine strategies for the treatment of lymphoma: preclinical progress and clinical trial update |
Search more.